A detailed history of Yousif Capital Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Yousif Capital Management, LLC holds 928 shares of ARGX stock, worth $523,605. This represents 0.01% of its overall portfolio holdings.

Number of Shares
928
Previous 957 3.03%
Holding current value
$523,605
Previous $411,000 22.38%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$434.22 - $551.9 $12,592 - $16,005
-29 Reduced 3.03%
928 $503,000
Q4 2023

Feb 01, 2024

BUY
$338.91 - $506.01 $6,778 - $10,120
20 Added 2.13%
957 $364,000
Q2 2023

Aug 02, 2023

BUY
$360.14 - $422.58 $6,482 - $7,606
18 Added 1.96%
937 $365,000
Q3 2022

Nov 04, 2022

BUY
$343.2 - $395.75 $44,616 - $51,447
130 Added 16.48%
919 $324,000
Q4 2021

Jan 31, 2022

BUY
$272.01 - $353.03 $214,615 - $278,540
789 New
789 $276,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.